Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10326339rdf:typepubmed:Citationlld:pubmed
pubmed-article:10326339lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:10326339lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10326339lifeskim:mentionsumls-concept:C0596171lld:lifeskim
pubmed-article:10326339lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:10326339lifeskim:mentionsumls-concept:C0764680lld:lifeskim
pubmed-article:10326339lifeskim:mentionsumls-concept:C0439185lld:lifeskim
pubmed-article:10326339pubmed:issue4 Suppllld:pubmed
pubmed-article:10326339pubmed:dateCreated1999-5-20lld:pubmed
pubmed-article:10326339pubmed:abstractTextIn recent years, skin grafting has evolved from the initial autograft and allograft preparations to biosynthetic and tissue-engineered living skin replacements. This review details the pioneering work of numerous investigators that led to the following precursors of tissue-engineered skin replacement: cultured autologous keratinocyte grafts, cultured allogeneic keratinocyte grafts, autologous/allogeneic composites, acellular collagen matrices, and cellular matrices. It also discusses the rationale for the development of the newer products and describes the technical advances leading to the development of Apligraf, a tissue-engineered human skin product.lld:pubmed
pubmed-article:10326339pubmed:languageenglld:pubmed
pubmed-article:10326339pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10326339pubmed:citationSubsetNlld:pubmed
pubmed-article:10326339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10326339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10326339pubmed:statusMEDLINElld:pubmed
pubmed-article:10326339pubmed:issn1076-2191lld:pubmed
pubmed-article:10326339pubmed:authorpubmed-author:EaglsteinW...lld:pubmed
pubmed-article:10326339pubmed:authorpubmed-author:FalangaVVlld:pubmed
pubmed-article:10326339pubmed:issnTypePrintlld:pubmed
pubmed-article:10326339pubmed:volume11lld:pubmed
pubmed-article:10326339pubmed:ownerNLMlld:pubmed
pubmed-article:10326339pubmed:authorsCompleteYlld:pubmed
pubmed-article:10326339pubmed:pagination1-8lld:pubmed
pubmed-article:10326339pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:meshHeadingpubmed-meshheading:10326339...lld:pubmed
pubmed-article:10326339pubmed:articleTitleTissue engineering and the development of Apligraf a human skin equivalent.lld:pubmed
pubmed-article:10326339pubmed:affiliationDepartment of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Florida, USA.lld:pubmed
pubmed-article:10326339pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10326339pubmed:publicationTypeReviewlld:pubmed
pubmed-article:10326339pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10326339pubmed:publicationTypeDuplicate Publicationlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10326339lld:pubmed